vs

Side-by-side financial comparison of Kennedy-Wilson Holdings, Inc. (KW) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Kennedy-Wilson Holdings, Inc. is the larger business by last-quarter revenue ($120.6M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). Kennedy-Wilson Holdings, Inc. runs the higher net margin — 48.1% vs -38.1%, a 86.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -11.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -6.0%).

Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

KW vs PRCT — Head-to-Head

Bigger by revenue
KW
KW
1.5× larger
KW
$120.6M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+31.2% gap
PRCT
20.2%
-11.0%
KW
Higher net margin
KW
KW
86.2% more per $
KW
48.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-6.0%
KW

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KW
KW
PRCT
PRCT
Revenue
$120.6M
$83.1M
Net Profit
$58.0M
$-31.6M
Gross Margin
64.9%
Operating Margin
57.3%
-4.1%
Net Margin
48.1%
-38.1%
Revenue YoY
-11.0%
20.2%
Net Profit YoY
32.7%
-27.9%
EPS (diluted)
$0.22
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KW
KW
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$120.6M
$76.4M
Q3 25
$116.4M
$83.3M
Q2 25
$135.7M
$79.2M
Q1 25
$128.3M
$69.2M
Q4 24
$135.5M
$68.2M
Q3 24
$127.5M
$58.4M
Q2 24
$132.0M
$53.4M
Net Profit
KW
KW
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$58.0M
$-29.8M
Q3 25
$-10.2M
$-21.4M
Q2 25
$5.6M
$-19.6M
Q1 25
$-29.6M
$-24.7M
Q4 24
$43.7M
$-18.9M
Q3 24
$-66.8M
$-21.0M
Q2 24
$-48.3M
$-25.6M
Gross Margin
KW
KW
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
KW
KW
PRCT
PRCT
Q1 26
-4.1%
Q4 25
57.3%
-40.6%
Q3 25
-6.2%
-27.8%
Q2 25
7.4%
-28.0%
Q1 25
-26.9%
-39.7%
Q4 24
36.7%
-28.9%
Q3 24
-60.8%
-38.4%
Q2 24
-45.5%
-50.3%
Net Margin
KW
KW
PRCT
PRCT
Q1 26
-38.1%
Q4 25
48.1%
-39.1%
Q3 25
-8.8%
-25.7%
Q2 25
4.1%
-24.7%
Q1 25
-23.1%
-35.8%
Q4 24
32.3%
-27.6%
Q3 24
-52.4%
-35.9%
Q2 24
-36.6%
-48.0%
EPS (diluted)
KW
KW
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.22
$-0.54
Q3 25
$-0.15
$-0.38
Q2 25
$-0.05
$-0.35
Q1 25
$-0.30
$-0.45
Q4 24
$0.24
$-0.34
Q3 24
$-0.56
$-0.40
Q2 24
$-0.43
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KW
KW
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$184.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$1.5B
$347.7M
Total Assets
$6.6B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KW
KW
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$184.5M
$286.5M
Q3 25
$382.6M
$294.3M
Q2 25
$309.1M
$302.7M
Q1 25
$356.6M
$316.2M
Q4 24
$217.5M
$333.7M
Q3 24
$367.1M
$196.8M
Q2 24
$366.5M
$214.1M
Total Debt
KW
KW
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
KW
KW
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$1.5B
$365.9M
Q3 25
$1.5B
$380.3M
Q2 25
$1.6B
$385.8M
Q1 25
$1.6B
$389.2M
Q4 24
$1.6B
$402.2M
Q3 24
$1.6B
$241.2M
Q2 24
$1.7B
$251.8M
Total Assets
KW
KW
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$6.6B
$508.1M
Q3 25
$6.7B
$511.5M
Q2 25
$6.8B
$513.1M
Q1 25
$7.2B
$519.4M
Q4 24
$7.0B
$534.0M
Q3 24
$7.4B
$374.1M
Q2 24
$7.5B
$374.4M
Debt / Equity
KW
KW
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KW
KW
PRCT
PRCT
Operating Cash FlowLast quarter
$11.4M
Free Cash FlowOCF − Capex
$-55.2M
FCF MarginFCF / Revenue
-45.8%
Capex IntensityCapex / Revenue
55.2%
Cash ConversionOCF / Net Profit
0.20×
TTM Free Cash FlowTrailing 4 quarters
$-103.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KW
KW
PRCT
PRCT
Q1 26
Q4 25
$11.4M
$-10.3M
Q3 25
$-7.6M
$-6.6M
Q2 25
$42.0M
$-15.0M
Q1 25
$-51.9M
$-17.0M
Q4 24
$55.1M
$-32.4M
Q3 24
$-5.6M
$-18.8M
Q2 24
$36.7M
$-15.7M
Free Cash Flow
KW
KW
PRCT
PRCT
Q1 26
Q4 25
$-55.2M
$-12.2M
Q3 25
$-18.0M
$-9.5M
Q2 25
$29.4M
$-17.8M
Q1 25
$-59.7M
$-18.8M
Q4 24
$-76.5M
$-33.6M
Q3 24
$-27.7M
$-19.0M
Q2 24
$-500.0K
$-16.8M
FCF Margin
KW
KW
PRCT
PRCT
Q1 26
Q4 25
-45.8%
-15.9%
Q3 25
-15.5%
-11.4%
Q2 25
21.7%
-22.5%
Q1 25
-46.5%
-27.2%
Q4 24
-56.5%
-49.2%
Q3 24
-21.7%
-32.6%
Q2 24
-0.4%
-31.4%
Capex Intensity
KW
KW
PRCT
PRCT
Q1 26
Q4 25
55.2%
2.4%
Q3 25
8.9%
3.4%
Q2 25
9.3%
3.5%
Q1 25
6.1%
2.7%
Q4 24
97.1%
1.7%
Q3 24
17.3%
0.4%
Q2 24
28.2%
2.0%
Cash Conversion
KW
KW
PRCT
PRCT
Q1 26
Q4 25
0.20×
Q3 25
Q2 25
7.50×
Q1 25
Q4 24
1.26×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KW
KW

Consolidated Portfolio Segment$84.9M70%
Investment Management Fees$30.4M25%
Real Estate$5.1M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons